Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Immunogenicity and Safety of Adjuvanted vs Non-Adjuvanted Influenza Vaccine in Children
NCT00408395Phase 2Completed
- Sponsor
- Novartis
- Start
- Nov 2006
- Primary completion
- Aug 2007
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 2, randomised, single-blind trial of influenza vaccine (surface antigen, inactivated, adjuvanted) in influenza (2 arms), sponsored by Novartis. Primary endpoint: Geometric Mean Titers. Started Nov 2006; status: completed.
02
Drugs
influenza vaccine (surface antigen, inactivated, adjuvanted)
03
Conditions
influenza
Beyond the preview
Go deeper on NCT00408395.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00408395.